Harnessing Pathogen Genomics to Understand and Control Antimicrobial Resistance

Exploration of the genomic diversity of third-generation cephalosporin-resistant Escherichia coli in Australian clinical settings

M Maqbool, NL Sherry, JC Kwong, BP Howden, CL Gorrie, DJ Ingle

2026-01-01

Escherichia coli resistant to third-generation cephalosporins (3GCs) is a WHO priority pathogen due to its antimicrobial resistanc..

Bringing tuberculosis genomics to the clinic: development and validation of a comprehensive pipeline to predict antimicrobial susceptibility from genomic data, accredited to ISO standards

KA Horan, L Viberg, SA Ballard, M Globan, W Wirth, K Bond, JR Webb, T Dorji, DA Williamson, ML Sait, EL Tay, JT Denholm, BP Howden, T Seemann, NL Sherry

2025-12-01

BackgroundWhole-genome sequencing is increasingly contributing to the clinical management of tuberculosis. Although the availabili..

Population structure and antimicrobial resistance of Corynebacterium diphtheriae in Victoria, Australia

LS Kumar, SL Baines, K Hui, J Strachan, NL Sherry, BP Howden

2025-10-01

Corynebacterium diphtheriae, the main aetiological agent of diphtheria, is a re-emerging bacterial pathogen of public health conce..

Genomics to understand the global landscape of linezolid resistance in Enterococcus faecium and Enterococcus faecalis

JQ Beh, DS Daniel, LM Judd, RR Wick, P Kelley, KM Cronin, NL Sherry, BP Howden, CH Connor, JR Webb

2025-01-01

Linezolid is an oxazolidinone antibiotic and is a last-line agent for treating infections caused by vancomycin-resistant Enterococ..